Weak Opening
Stocks appeared set to open weak
Tuesday, ahead of one of the
heaviest reporting days of the earnings season.
Nuance Communications
(
NUAN |
Quote |
Chart |
News |
PowerRating)
announced that UBS will be using the company’s natural language speech
recognition technology.
Immunex
(
IMNX |
Quote |
Chart |
News |
PowerRating) has submitted its
fourth application requesting approval from the FDA for its product Enbrel. Immunex has requested “priority review” status.
Pfizer
(
PFE |
Quote |
Chart |
News |
PowerRating) reported Q2 earnings
of 30 cents a share, beating analyst consensus by a penny.
Global Marine
(
GLM |
Quote |
Chart |
News |
PowerRating) announced Q2
earnings of 34 cents a share in line with analysts’ expectations.
Biogen
(
BGEN |
Quote |
Chart |
News |
PowerRating) reported earnings
for Q2 of 47 cents a share, a penny above analyst consensus.
AOL Time Warner
(
AOL |
Quote |
Chart |
News |
PowerRating) and Samsung
Electronics have strategically aligned to market and develop technology for the
next generation of AOLTV which will feature functions from the TiVo
(
TIVO |
Quote |
Chart |
News |
PowerRating)
service.
Target Stores
(
TGT |
Quote |
Chart |
News |
PowerRating) and Tupperware
(
TUP |
Quote |
Chart |
News |
PowerRating) have come to an agreement allowing TGT to offer 40 to 50 Tupperware
products in all 62 SuperTarget Stores.
Biotechnology firm Geron
(
GERN |
Quote |
Chart |
News |
PowerRating)
received a patent on the gene which encodes human telomerase.
Salomon Smith Barney downgraded
Sanmina
(
SANM |
Quote |
Chart |
News |
PowerRating) from a Buy to Outperform.
Symbol Techs
(
SBL |
Quote |
Chart |
News |
PowerRating) was downgraded
by Credit Suisse First Boston to a Hold from a Buy.
Bear Stearns upgraded Alcan Aluminum
(
AL |
Quote |
Chart |
News |
PowerRating)
from Attractive to Buy.
Intel
(
INTC |
Quote |
Chart |
News |
PowerRating) was down graded by
ABN Amro to Reduce from Hold.
Cor Therapeutics
(
CORR |
Quote |
Chart |
News |
PowerRating) reported
Q2 earnings of 6 cents a share. Analysts polled by Thomson Financial/First Call
were expecting earnings of 5 cents.
Parametric Technology
(
PMTC |
Quote |
Chart |
News |
PowerRating) said
Q3 earnings fell 6% and would be taking a Q4 charge for cost cutting measures.
The company earned 3 cents a share. On average, analysts were expecting 3 cents a
share according to Thomson Financial/First Call.
Merrill Lynch
(
MER |
Quote |
Chart |
News |
PowerRating) said
Q2 earnings fell 41% due to a weak stock market. MER reported EPS of 56 cents.
Analysts surveyed by Thomson Financial/First Call lowered expectations to 54
cents a share for Q2, after Merrill issued a profit warning last month.
IDEXX Labroratories
(
IDXX |
Quote |
Chart |
News |
PowerRating)
reported an increase of 4.6% for Q2 earnings. IDXX made 29 cents per diluted
share, in line with analysts’ expectations according to a survey taken by Thomson
Financial/First Call.